OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Coleman on Ongoing Research in Cervical Cancer

November 14th 2019

Robert L. Coleman, MD, FACOG, FACS, discusses ongoing research efforts in cervical cancer.

Dr. Long on Rationale for Nivolumab/Ipilimumab in Patients With Melanoma Who Have Brain Mets

November 14th 2019

Georgina V. Long, BSc, PhD, MBBS, FRACP, discusses the rationale for the combination of nivolumab (Opdivo) and ipilimumab (Yervoy) in patients with melanoma who have brain metastases.

Dr. Fidler on RELAY Trial Results in EGFR+ NSCLC

November 14th 2019

Mary J. Fidler, MD, discusses the results of the phase III RELAY trial in treatment-naïve patients with EGFR-mutant non–small cell lung cancer.

Dr. Nooka on Treatment Options for Transplant-Eligible and -Ineligible Multiple Myeloma

November 14th 2019

Ajay K. Nooka, MD, MPH, FACP, discusses current options for transplant-eligible and -ineligible patients with multiple myeloma.

Dr. Vargas on Toxicity of SBRT Versus Standard Radiation in Prostate Cancer

November 13th 2019

Carlos E. Vargas, MD, discusses toxicities associated with stereotactic body radiation therapy compared with standard fractionated radiation therapy in prostate cancer.

Dr. Rule on the Future Treatment Paradigm in MCL

November 13th 2019

Simon Rule, MD, PhD, discusses what the treatment landscape of mantle cell lymphoma may look like in the next decade.

Dr. Kris on Search for Biomarkers in Advanced Squamous NSCLC

November 13th 2019

Mark G. Kris, MD, discusses the ongoing search for additional biomarkers in advanced squamous non–small cell lung cancer.

Dr. Borello on Treating Indolent Versus Aggressive Relapsed Multiple Myeloma

November 12th 2019

Ivan M. Borrello, MD, discusses treatment for patients with indolent versus aggressive relapsed multiple myeloma.

Dr. Gogineni on Implications of the APT Trial in HER2+ Breast Cancer

November 12th 2019

Keerthi Gogineni, MD, MSHP, discusses the clinical implications of the phase II APT trial in HER2-positive breast cancer.

Dr. Ocean on Efforts to Improve Early Detection in Pancreatic Cancer

November 12th 2019

Allyson Ocean, MD, discusses efforts to improve early detection rates in pancreatic cancer.

Dr. Backes on Safety Profile of Lenvatinib and Weekly Paclitaxel in Endometrial Cancer

November 12th 2019

Floor J. Backes, MD, discusses the safety profile from a phase I study looking at lenvatinib and weekly paclitaxel in women with recurrent endometrial cancer.

Dr. Hamilton on the Impact of Biosimilars in Oncology

November 12th 2019

Erika P. Hamilton, MD, discusses the impact of biosimilars in oncology.

Dr. Jonasch on Modulating the Tumor Microenvironment in RCC

November 12th 2019

Eric Jonasch, MD, discusses how to modulate the tumor microenvironment in renal cell carcinoma.

Dr. Yadav on Differences in Type 1 and Type 2 Uterine Cancer

November 12th 2019

Ghanshyam Yadav, MD, discusses the differences between type 1 and type 2 uterine cancer.

The Heterogeneity of Biologics

November 12th 2019

Jim M. Koeller, MS FHOPA, discusses the heterogeneity of biologics.

Dr. Stiles on Surgical Considerations in Lung Cancer

November 12th 2019

Brendon Stiles, MD, discusses considerations for surgery in lung cancer.

Dr. Eng on Unmet Needs in Early-Onset CRC

November 12th 2019

Cathy Eng, MD, FACP, FASCO, discusses unique barriers facing patients with early-onset colorectal cancer.

Dr. Ho on First-Line TKI Monotherapy in mRCC

November 12th 2019

Thai H. Ho, MD, PhD, discusses the role of TKI monotherapy in the first-line treatment of patients with metastatic renal cell carcinoma.

Dr. Cosgrove on Selecting a PARP Inhibitor for Maintenance Therapy in Ovarian Cancer

November 12th 2019

Casey M. Cosgrove, MD, discusses factors to consider when selecting a PARP inhibitor as maintenance therapy in advanced ovarian cancer.

Dr. Lonial on Treating Early Relapse in Multiple Myeloma

November 12th 2019

Sagar Lonial, MD, FACP, discusses the management of patients with relapsed multiple myeloma.